Who we are

AxialBridge is a female founded company providing extensive experience supporting the life cycle of taking new therapies from concept through clinical trials and to market.

Our Company

Founded in early 2020, we are passionate about changing the health paradigm from traditional pharmaceuticals, by supporting the movement towards the adoption of precision medicine focused on unmet current and future medical needs of people globally.

Our organization is dedicated to the advancement of novel therapeutics, devices and digital health platforms by providing a more targeted and customised approach including strategic services from preclinical advisory, pre-phase I strategic advisory support up to commercialization, including reimbursement & market access strategies.

Our Team

At AxialBridge, we have a diverse and inclusive culture and this carries through to our hiring practices; impacting the way we deliver our services including our goal of addressing prominent industry inequities such as who receives investments, targeting new therapies to meet historically unmet patient populations, and ensuring diverse populations in clinical trials.  

CHIEF EXECUTIVE OFFICER & CO-FOUNDER

Jaspreet Grewal MSc, MBA, CCRP

  • Jaspreet Grewal is an accomplished Clinician-Researcher turned Venture Partner, Strategic Consultant and Board Director with nearly 20 years of experience in the healthcare and life sciences industries. She is a published researcher with experience in over a dozen therapeutic areas, and exposure to the largest healthcare investment markets in the world whilst working in clinical medicine, R&D (for pharmaceutical and medical device companies) and in an advisory capacity for biotech companies.

    Jaspreet holds a Master’s in Clinical Vision Sciences from Georgetown University, an Executive Certificate in Public Health from Harvard University and an Executive MBA from the London School of Economics and Political Science. She has successfully merged her expertise and passion for innovation, research and finance to become a dynamic leader not only nationally but internationally. She’s passionate about supporting her diverse international clientele in the areas of clinical research, strategic consulting and access to capital and deal flow.

    • Expert Advisor, Innovate Calgary

    • Board Director, BioAlberta

      • Audit & Finance Committee Member

      • Policy & Advocacy Committee Member

    • Founding Member, Alberta Life Sciences Investment Committee

    • Global Life Sciences Consultant, Calgary Economic Development

    • Chair, Clinical Research Association of Canada

    • Board Director, Heroic Hearts Canada

    • Charter Member, Canada UK Chamber of Commerce

DIRECTOR, CLINICAL OPERATIONS

Sabrina Ramkellawan CCRP CCRA

  • Sabrina Ramkellawan (She/Her) has previous experience as a registered nurse with critical care speciality and worked in a few therapeutic areas including ICU/CCU, Medical/Surgical CNS, Mental Health and community nursing. She has over 20+ years of clinical trial management experience in pharma, CROs and at research sites

    She has held positions at or advised some top pharmaceutical, research organizations and healthcare companies. She has previous experience leading operations at large scale global Contract Research Organizations including INC Research (now Syneos Health). Sabrina also assisted in the development of an early phase contract research organization including leading a number of successful regulatory inspections.

    She has conducting phase I-IV in Rare Disease, Ophthalmology, CNS/Nuerology, Hematology, Gastroenterology, Dermatology and more. In addition, her experience includes vaccines, novel therapeutics, biologics, generics, implants, medical devices and digital health products.

    Sabrina is passionate about education and has helped to build and was an instructor at Michener Institute of Education at the University Health Network (UHN) in Toronto. She also helped to build and was a previous instructor for the clinical research program at Seneca College. Sabrina is also the President of the Clinical Research Organization of Canada which provides education and accreditation for researchers in Canada.

    Prior to her role at AxialBridge, Sabrina had various senior roles and consulting roles in research organizations, biotech and life science companies. In her role as Director, Clinical Operations at AxialBridge, she is focused on all operational aspects of conducting research including functional support professional as needed.

    • President, Clinical Research Association of Canada

    • Advisory Member, Seneca College, Cannabis Regulation and Quality Assurance Program

    • MAPs Canada, Board of Directors and Co-Chair

ADVISOR, NATIONAL DEFENSE PARTNERSHIPS & AI

CDR (Ret.) Stephen Jones, MBA, MPA

  • Stephen Jones is a Texas native raised in Midland, Michigan, who graduated from Purdue University in May 1998 with a Bachelor of Science degree in Management and a minor in Finance. After completing Officer Candidate School in Pensacola, Florida, he was commissioned an Ensign in September 1998 and was designated a Naval Aviator in August 2000.

    Stephen served in the United States Navy for over 20 years as a Naval Aviator and Commanding Officer. During his military career, he accumulated over 3,500 flight hours in multiple rotary and fixed-winged aircraft, supporting numerous campaigns worldwide.

    Since retirement, Stephen has served as the Vice President of the Global SOF Foundation (GSF), a 501(c)(3) educational non-profit organization dedicated to advocating for all aspects of SOF on a global scale. Stephen also served as the Senior Vice President of Skymount Medical, an Artificial Intelligence and Machine Learning company that uses its AI/ML platform to identify, filter, develop, and accelerate custom drug discovery. Stephen serves as the Managing Director of the Veterans Cannabis Project (VCP). The VCP is a non-profit dedicated to improving U.S. military veterans’ quality of life through the opportunity of cannabis. The VCP believes medical cannabis saves lives and that veterans deserve full legal access.

    Stephen holds a bachelor's degree from Purdue University and two Master's degrees from the University of West Florida and the Naval Postgraduate School. Upon retirement, Stephen earned a Master of Public Administration from the Harvard Kennedy School of Government. His professional experiences span global development, organizational development, innovation, macroeconomics, security cooperation, defense financial management, and acquisitions.

SENIOR REGULATORY AFFAIRS & QUALITY MANAGEMENT CONSULTANT

Andjica Tasic CQA, CCRP

  • Andjica Tasic is a versatile professional with over 25 years of experience in the medical and pharmaceutical fields managing clinical trials with a focus on Regulatory and Quality. She has had positions in senior regulatory affairs and quality assurance roles including VP Global Quality Assurance and Regulatory Affairs at CROs in Canada and the US. She has been responsible for regulatory submission and approvals for phase 1-3 clinical trials in countries globally including Health Canada, the US FDA, UK MHRA and across Europe including EMEA. She has extensive experience submitting drug master files and has conducted many regulatory submissions. Andjica can provide regulatory advisory and strategy including assessing if a company has the appropriate strategy and regulatory readiness depending on the regulatory jurisdiction and country.

    Recognized by many companies for her hard work and dedication as a company solo representative during regulatory body inspections, Andjica has prepared for and hosted numerous regulatory inspections by the FDA, Health Canada and EMEA. She also has experience with vendor selection and audits. Flexible and multi-tasking with excellent interpersonal, communication and negotiation skills, and superlative time management and organizational skills, she is committed to the principles and practices that result in high quality products and clinical trial management services.

SCIENTIFIC AND REGULATORY COMPLIANCE CONSULTANT

Ana Dukic, CMC

  • Ana has experience in the pharmaceutical, life sciences and clinical research for more then eight years. She has held regulatory compliance positions at various research organizations and supported many companies in bringing their products and devices to US, Canadian and European markets. Ana is passionate about improving clinical trials through science and providing validated data for novel therapies.

    Ana has strong academic background and experience in many therapeutic areas, from mental health and oncology studies to cardiovascular drugs and pulmonary device development. She also has previous experience with validating laboratory procedures and supporting regulatory submissions. Ana’s biggest strengths are excellent problem-solving skills and quality commitment to all projects.

SENIOR RESEARCH CONSULTANT

Gazal Vakili

  • Gazal is a highly experienced global clinical research professional, with over 15 years of experience in diverse areas encompassing global clinical operations, clinical monitoring and QA, patient recruitment/retention, regulatory affairs, and data management. She has over 8 years of experience in managing/overseeing clinical trials for a Parkinson’s disease drug from the time of IND filing to NDA and FDA/Health Canada approvals. She has extensive expertise in decentralized/virtual clinical trials, Digital health, Prescription Digital Therapeutics, SaMD, and Virtual Reality Interventions for the treatment of mental health disorders. She has a Honors BSc. degree in Biology and Psychology, as well as a Master of Health Sciences (MSHS) degree in Clinical Research from George Washington University.

MEDICAL AFFAIRS CONSULTANT

Dr. Leon Barron BSc, MMUS, MBBS, MRCGP

  • As a GP he firmly believes in a holistic approach to medicine, focusing on the person as a whole rather than just the symptoms and disease in question. He has a keen interest in mental health and enjoys the challenge of combining the psychological and social aspects of care with physical health of patients. He has developed a strong interest in medical cannabis as an alternative therapy for patients who have not found conventional therapies to be effective. He is the co-founder and current Chair of The Medical Cannabis Clinicians Society. Leon also enjoys teaching roles and is a visiting tutor and examiner at University College London Medical School.

  • A senior team each with over 15 years of experience in Regulatory Affairs, Quality Management, Drug Development and conducting Phase I to IV Clinical Trials

  • Experience bringing therapies and devices from discovery to market

  • Broad range to therapeutic experience including Mental Health, CNS/Neurology, Ophthalmology, Sleep Medicine, Gastroenterology, Dermatology, Oncology, Rare Diseases, and Chronic and Neuropathic Pain conditions and more.

  • Support for decentralized trials, digital health products and ability to advise on the use of AI in drug discovery.

  • Reimbursement and Market Access Expertise

  • Supporting investment and fundraising activities with a global network of funders (Venture Capital, Private Equity, Family Office and Corporate Finance)